B. Bai

发表

HER2-positive breast cancer patients receiving trastuzumab treatment obtain prognosis comparable with that of HER2-negative breast cancer patients

Zhongyu Yuan, R. Peng, Yanxia Shi, 2013, OncoTargets and therapy.

HER 2-positive breast cancer patients receiving trastuzumab treatment obtain prognosis comparable with that of HER 2-negative breast cancer patients

Zhongyu Yuan, R. Peng, Yanxia Shi, 2013 .

Persistent peripheral blood EBV-DNA positive with high expression of PD-L1 and upregulation of CD4 + CD25 + T cell ratio in early stage NK/T cell lymphoma patients may predict worse outcome

Wen-Qi Jiang, Hui-Qiang Huang, Zhiming Li, 2018, Annals of Hematology.

Identifying high-risk patients with natural killer/T-cell lymphoma undergoing autologous stem cell transplantation

Hui-Qiang Huang, Yan Gao, Peng-fei Li, 2020, Leukemia & lymphoma.

Promising long-term outcome of gemcitabine, vinorelbine, liposomal doxorubicin (GVD) in 14-day schedule as salvage regimen for patients with previously heavily treated Hodgkin’s lymphoma and aggressive non-Hodgkin’s lymphoma

Hui-Qiang Huang, Yi Xia, Q. Cai, 2013, Medical Oncology.

The emerging role of anti-PD-1 antibody-based regimens in the treatment of extranodal NK/T-cell lymphoma-associated hemophagocytic lymphohistiocytosis

Hui-Qiang Huang, Zhiming Li, Q. Cai, 2022, Journal of Cancer Research and Clinical Oncology.

Clinical outcomes of patients with newly diagnosed primary central nervous system lymphoma are comparable on treatment with high-dose methotrexate plus temozolomide and with high-dose methotrexate plus cytarabine: a single-institution experience

Wen-Qi Jiang, Y. Xia, Hui-Qiang Huang, 2014, Leukemia & lymphoma.

Association of circulating tumor DNA from the cerebrospinal fluid with high-risk CNS involvement in patients with diffuse large B-cell lymphoma.

Xue Wu, Y. Shao, Q. Ou, 2020, Clinical and translational medicine.

High numbers of tumor-associated macrophages correlate with poor prognosis in patients with mature T- and natural killer cell lymphomas

Xiangyuan Wu, Q. Cai, B. Bai, 2012, Medical Oncology.

Safety and efficacy of non-initial rapid infusion of rituximab plus chemotherapy in Chinese patients with CD20+ non-Hodgkin’s lymphoma

Wei Zhao, Q. Cai, Yan Gao, 2015, Expert opinion on drug safety.

Clinical features and survival analysis of different subtypes of patients with breast cancer brain metastases.

Zhongyu Yuan, Dong-geng Liu, B. Bai, 2010, Chinese journal of cancer.

Re-Clustering and Profiling of Digestive System Tumors According to Microenvironment Components

Shuo Wang, Sen Guo, Yaxian Gao, 2020, Frontiers in Oncology.

Long-term results of the R-CEOP90 in the treatment of young patients with chemotherapy-naïve diffuse large B cell lymphoma: A phase II study

Q. Cai, Yan Gao, B. Bai, 2014, Leukemia & lymphoma.

Double inv(3)(q21q26.2) in acute myeloid leukemia is resulted from an acquired copy neutral loss of heterozygosity of chromosome 3q and associated with disease progression

H. Kantarjian, K. Patel, L. Medeiros, 2015, Molecular Cytogenetics.

Treatment outcome of docetaxel, capecitabine and cisplatin regimen for patients with refractory and relapsed nasopharyngeal carcinoma who failed previous platinum-based chemotherapy

Q. Cai, Yan Gao, B. Bai, 2014, Expert opinion on pharmacotherapy.

Systematic Oxidative Stress Indexes Associated with the Prognosis in Patients with T Lymphoblastic Lymphoma/Leukemia

Yan Gao, B. Bai, Xiao-xiao Wang, 2022, Oxidative medicine and cellular longevity.

Pralatrexate in Chinese Patients with Relapsed or Refractory Peripheral T-cell Lymphoma: A Single-arm, Multicenter Study

Yuankai Shi, Jun Zhu, X. Ke, 2019, Targeted Oncology.

Prognostic significance of proline, glutamic acid, leucine rich protein 1 (PELP1) in triple-negative breast cancer: a retrospective study on 129 cases

Meilin Liu, H. Sasano, K. McNamara, 2015, BMC Cancer.

Double inv(3)(q21q26.2) in acute myeloid leukemia is resulted from an acquired copy neutral loss of heterozygosity of chromosome 3q and associated with disease progression

H. Kantarjian, K. Patel, L. Medeiros, 2015, Molecular Cytogenetics.

IL-6 Promotes Cell Proliferation and Antiapoptosis Through Activation Of The JAK/STAT3 Pathway In Patients With NK/T - Cell Lymphoma and Correlates With Poor Treatmemt Outcome

Yi Xia, Jia-bin Lu, Yan Gao, 2013 .

A TNM Staging System for Nasal NK/T-Cell Lymphoma

Wen-Qi Jiang, Chuan-miao Xie, Wei Zhao, 2015, PloS one.

Individualized management of follicular lymphoma.

B. Bai, Huiqiang Huang, 2015, Chinese clinical oncology.

Prior anti-PD-1 therapy as a risk factor for life-threatening peri-engraftment respiratory distress syndrome in patients undergoing autologous stem cell transplantation

Yan Gao, Peng-fei Li, B. Bai, 2020, Bone Marrow Transplantation.

High IL-6 expression in the tumor microenvironment is associated with poor prognosis of patients with extranodal natural / killer T-cell lymphoma (ENKTL)

Q. Cai, Wenqi Jiang, Zhiming Li, 2021, Expert review of anticancer therapy.

The beneficial effect of Escalated‐R‐CHOP‐21 for the treatment of diffuse large B‐cell lymphoma in elderly male patients: A propensity‐matched cohort study

Wen-Qi Jiang, Zhiming Li, Jibin Li, 2021, Cancer medicine.

VISTA and PD-L1 synergistically predict poor prognosis in patients with extranodal natural killer/T-cell lymphoma

Qiang-hua Zhou, Xu Chen, Yan Gao, 2021, Oncoimmunology.

Predictive value of pretreatment positron emission tomography/computed tomography in patients with newly diagnosed extranodal natural killer/T-cell lymphoma

Wen-Qi Jiang, Y. Xia, Xu Zhang, 2013, Medical Oncology.

Clinicopathologic characteristics and prognostic factors for HER2-positive patients with metastatic breast cancer in southern China

Zhongyu Yuan, R. Peng, Yan-Xia Shi, 2015, Archives of medical science : AMS.

Efficacy and Safety Of Pegaspargase With Gemcitabine and Oxaliplatin In Patients With Treatment-naïve, Refractory Extranodal Natural Killer/T-Cell Lymphoma: A Single-Centre Experience

Wei Zhao, Z. Guan, Wenqi Jiang, 2013 .

Immunogenic Cell Death (ICD)-Related Gene Signature Could Predict the Prognosis of Patients with Diffuse Large B-Cell Lymphoma

Yan Gao, B. Bai, Xiao-xiao Wang, 2022, Journal of personalized medicine.

Efficacy and tolerability of toremifene and tamoxifen therapy in premenopausal patients with operable breast cancer: a retrospective analysis.

Zhongyu Yuan, R. Peng, Yanxia Shi, 2013, Current oncology.

Differential clinical significance of pre-, interim-, and post-treatment plasma Epstein–Barr virus DNA load in NK/T-cell lymphoma treated with P-GEMOX protocol

Wen-Qi Jiang, Zhiming Li, Yu-jing Zhang, 2019, Leukemia & lymphoma.

Preliminary Results of a Phase II Study of Methotrexate in Combination with Ibrutinib and Temozolomide (MIT) in Newly Diagnosed Primary CNS Lymphoma

Shanshan Yu, Y. Shao, Q. Ou, 2021, Blood.

t(1;3)(p36;p21) as the Sole Clonal Abnormality in Refractory Acute Myeloid Leukemia

C. Yin, Shimin Hu, G. Lu, 2012 .

PD-1 blockade combined with ICE regimen in relapsed/refractory diffuse large B-cell lymphoma

Yan Gao, B. Bai, Xiao-xiao Wang, 2023, Annals of Hematology.

Baseline expression of immune gene modules in blood is associated with primary response to anti-TNF therapy in Crohn's disease patients

T. Ahmad, C. Anderson, M. Reppell, 2023, medRxiv.

The emerging role of anti-PD-1 antibody-based regimens in the treatment of extranodal NK/T-cell lymphoma-associated hemophagocytic lymphohistiocytosis

Zhiming Li, Q. Cai, Yan Gao, 2022, Journal of Cancer Research and Clinical Oncology.

Clinical Outcome of P-Gemox ( Pegaspargase, Gemcitabine, Oxaliplatin ) for the Patients with Newly Diagnosed Stage III/IV or Relapsed/Refractory Extranodal Natural Killer/T Cell Lymphoma

Wei Zhao, Wenqi Jiang, Z. Xia, 2015 .